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Abstract Major transitions can be expected within the next
few decades aiming at the reduction of pollution and global
warming and at energy saving measures. For these purposes,
new sustainable biorefinery concepts will be needed that will
replace thetraditionalmineraloil-basedsynthesisofspecialty
and bulk chemicals. An important group of these chemicals
are those that comprise N-functionalities. Many plant
components contained in biomass rest or waste stream
fractions contain these N-functionalities in proteins and free
amino acids that can be used as starting materials for the
synthesisofbiopolymersandchemicals.Thispaper describes
the economic and technological feasibility for cyanophycin
production by fermentation of the potato waste stream
Protamylasse™ or directly in plants and its subsequent
conversion to a number of N-containing bulk chemicals.
Keywords Biorefinery.Plantwaste,reststream.
Protamylasse.Cyanophycin.Non-ribosomal.
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Introduction
Plants have the ability to use the incident sunlight for the
biosynthesis of a tremendous variety of compounds that may
contain a number of functionalized atoms or groups. An
important group of these functionalized compounds are
proteinsandespeciallythe individualaminoacidsthatcontain
one or more nitrogen atoms. When starting from crude oil or
naphtha, the incorporation of functionalities (e.g., −NH2)i n t o
derived bulk chemicals (such as 1,2-ethanediamine and 1,4-
butanediamine) requires considerable amounts of energy and
catalysts. However, some amino acids appear to be very
suitable starting materials for highly functionalized bulk
chemicals (Scott et al. 2007).
The biorefinery concept is a rapidly emerging field of
research and commercial activities aiming at the integral
use of all components of agricultural crops. In addition to
the main product such as starch or oil, also, other side
stream fractions including protein, free amino acid, and
fiber fractions have high potential for valorization. An
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remains after starch and protein extraction from potato and its
possible application as a substrate for microbial fermentation
and production process for cyanophycin (Elbahloul et al.
2005a,b, 2006), willbe describedindetailinthecurrentpaper.
Cyanophycin (multiarginyl-poly[L-aspartic acid]; CGP,
cyanophycin granule peptide) is a non-ribosomal protein-
like polymer which consists of equimolar amounts of aspartic
acid and arginine arranged as a poly-aspartic acid backbone
to which arginine residues are linked to the β-carboxyl group
of each aspartate by its α-amino group. In nature, cyano-
phycin is produced by most, but not all, cyanobacteria as a
temporary nitrogen reserve material during the transition of
cells from the exponential phase to the stationary phase. The
polymerization reaction is catalyzed by only one enzyme,
which is referred to as cyanophycin synthetase (CphA).
Because of the low polymer content and the slow growth of
cyanobacteria resulting in only low cell densities, cyanobac-
teriaarenotsuitableforlarge-scaleproductionofcyanophycin.
Therefore, the cphA genes from a number of cyanobacteria
have been expressed in several bacteria, and, more recently,
also in plants. Furthermore, the polymer isolated from
recombinant strains contained lysine as an additional amino
acid constituent.
Now that cyanophycin can be produced in sufficient
amounts by pilot scale fermentations for studying its
material properties, it appears of biotechnological interest
because purified cyanophycin can be chemically converted
into a polymer with a reduced arginine content, which
might be used like poly-aspartic acid as a biodegradable
substitute for synthetic polyacrylate in various technical
processes. In addition, cyanophycin might also be of
interest for other applications when the hitherto unknown
physical and material properties of this polymer will be
revealed. On the other hand, cyanophycin is a convenient
source of the constituent amino acids that may be regarded
as nitrogen-functionalized precursor chemicals.
In the current paper, conditions will be discussed for the
technological and economic feasibility of cyanophycin
production by microbial fermentation and by cyanophycin
production directly in plants. The conditions for fermenta-
tive cyanophycin production will be based upon the use of
cheap substrates derived from agricultural waste streams
and the possible cyanophycin production simultaneously
with other fermentation products like ethanol. This aspect is
denoted process integration.
Biorefinery and its place in the production of chemicals
The depletion in fossil feedstocks, increasing oil prices and
the ecological problems associated with CO2 emissions, are
forcing the development of alternative resources for energy,
transport fuels, and chemicals: the replacement of fossil
resources with CO2 neutral biomass.
Potentially, biomass may be used to replace fossil raw
materials in several major applications: heat, electricity,
transport fuels, chemicals, and other industrial use. Each of
these groups represents about 20% of the total fossil
consumptionintheindustrializedcountries(OilMarketReport
of the International Energy Agency 2004). Large variations
in the cost of these products at the wholesale level, based
on their energy content, are evident (Table 1). When one
considers the contribution to costs by the raw materials
(expressed per GJ end product), large differences are also
seen. Heat can be produced from coal for around 3 €/GJ due
to utilizing inexpensive feedstocks with high conversion
efficiency (about 100%), while the raw material costs for
electricity is double (6 €/GJ) due to a conversion yield of
about 50%. Most notable is the high raw material costs for
chemicals. Here, expensive raw materials (oil) are used with
low(er) conversion yields (Sanders et al. 2005, 2007).
To obtain a good net income for biomass, an effective
biorefinery system is required for the separation of the
harvested crop into fractions for use in (several of) these
applications. These may be used directly as the desired
product or undergo conversion by chemical, enzymatic, and/
or microbial means to obtain other products. Biorefinery
systems are well established for a number of crops. For
example, soybeans are the raw materials for large biorefi-
neries to produce oil (for biofuels), proteins and valuable
nutraceuticals.
Less well explored is the use of biomass to make industrial
chemicals. Effort to produce chemicals with constant quality
and performance (such as lactic acid) has been addressed, but
has mainly focused on the use of carbohydrates as raw
materials and use of biotechnology for conversion. However,
for effective biorefinery approaches, other biomass fractions
shouldalsobeconsideredfortheproductionofchemicals.Itis
anticipated that the substitution of petrochemical transporta-
tion fuels with biofuels will rise significantly in the coming
years.Thismeansthatariseintheproductionofbiodieselwill
Table 1 Different applications and contributions of biomass
Contribution Integral
cost prices
(€/GJ end
product)
Raw material
cost fossil
(€/GJ)
Percentage of
total energy in
the Netherlands
(3.000 PJ)
consumed per
application (%)
Heat 4 3 (Coal) ±20
Electricity 22 6 (Coal) ±20
Transport fuel 10 8 (Oil) ±20
Average bulk chemicals 75 30 (Oil) ±20
Rest of industry ±20
258 Appl Microbiol Biotechnol (2007) 77:257–267lead to large volumes of glycerol as a residual stream, and
indeed, some companies are already investigating the use of
glycerol to produce chemicals. While the awareness of large
volumes of glycerol from biofuel production is apparent, one
shouldnot overlookother waste streams.Indeed, frombiofuel
production, an immense concomitant waste stream of protein
willalsobegenerated.Sourcesofproteinsandaminoacidsare
not limited to those generated from biofuel production, but
also from other industries such as potato starch production.
F o re x a m p l e ,d u r i n gA V E B E ’s processing of potatoes for
starch extraction, the main waste stream is Protamylasse™,
which mainly contains sugars, organic acids, proteins, and
free amino acids and has currently no major market use.
Some of the amino acids present in such sources could be
very suitable raw materials for preparing (highly) function-
alized chemicals traditionally prepared by the petrochemical
industry (Sanders et al. 2007).
Generally, the conversion of crude oil products utilizes
primary products (ethylene, etc.), and their conversion to
materials or (functional) chemicals makes use of co-reagents
such as ammonia and various process steps to introduce
functionalities such as −NH2. Conversely, many products
found in biomass, such as proteins and amino acids, often
contain these functionalities. Therefore, it is attractive to
exploit this to bypass the use, and preparation, of co-reagents
as well as eliminate various process steps by utilizing suitable
biomass-based precursors for the production of chemicals.
Thus, the production of chemicals from biomass takes
advantage of the biomass structure in a more efficient way
than the production of fuels or electricity alone and can
potentially save more fossil energy than producing energy
alone (Scott et al. 2007). When used in combination with
environmentally sound production and processing techniques
across the whole biomass production chain, i.e., from cultiva-
tion and harvest, its (pre)treatment and conversion to products,
the use of biomass is considered a sustainable alternative to
conventional feedstocks, which is reflected by sound economic
advantages in both raw material and investment costs.
General introduction on NRPs and especially
cyanophycin
Cyanophycin (also referred to as CGP, cyanophycin granule
polypeptide)thatbelongstothefamilyofbacterialpoly-amino
acids together with poly-γ-glutamic acid and poly-ɛ-lysine,
was discovered in 1887 by Borzi (1887)d u r i n gm i c r o s c o p i c
studies of cyanobacteria and was later found in all groups of
cyanobacteria (Oppermann-Sanio and Steinbüchel 2002).
The cyanophycin molecule structure is related to that of poly
(aspartic acid)s, but, unlike synthetic poly-aspartic acid, it is a
comb-like polymer with α-amino-α-carboxy-linked L-aspartic
acid residues representing the poly(α-L-aspartic acid) back-
bone and L-arginine residues bound to the β-carboxylic
groups of aspartic acids (Simon and Weathers 1976;f o r
recent review, see Obst and Steinbüchel 2004;F i g .1).
Cyanophycin is synthesized by most, but not all, cyanobacteria
as a temporary nitrogen reserve material during the transition of
cells from the exponential phase to the stationary phase
(Mackerras et al. 1990). At neutral pH and physiological ionic
strength, cyanophycin is insoluble and deposited in the
cytoplasm as membraneless granules (Lawry and Simon 1982).
Cyanophycin isolated from Cyanobacteria is highly
polydisperse and shows a molecular weight range of 25–
100 kDa as estimated by sodium dodecylsulphate polyacryl-
amide gel electrophoresis corresponding to a polymerization
degree of 90–400 (Simon 1971; Simon and Weathers 1976).
Cyanophycin is a transiently accumulated storage compound
which is synthesized under conditions of low temperature or
low light intensity. Its accumulation can be artificially
enhanced by the addition of chloramphenicol as an inhibitor
of ribosomal protein biosynthesis (Simon 1973). Cyanophy-
cin plays an important role in the conservation of nitrogen,
carbon, and energy and, as indicated by its biosynthesis in
presence of chloramphenicol, is non-ribosomally synthesized
by CphA. Cyanophycin is accumulated in the cytoplasm of
cyanobacteria as membraneless granules (Allen and
Weathers 1980)i nt h ee a r l ys t a t i o n a r yg r o w t hp h a s e
(Mackerras et al. 1990; Liotenberg et al. 1996). When growth
is resumed, for example due to a change in cultivation
conditions, cyanophycin is reutilized by the cells (Mackerras
et al. 1990). Krehenbrink et al. (2002) and Ziegler et al.
(2002) showed that cyanophycin occurs even in heterotro-
phic bacteria like Acinetobacter sp. and Desulfitobacterium
hafniense and therefore confirmed the wide distribution of
this biopolymer and its function in nature as a general
storage compound.
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Fig. 1 Chemical structure of the
cyanophycin monomer
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purified polymer can be chemically converted into a
polymer with reduced arginine content (Joentgen et al.
1998), which might be used like poly-aspartic acid as a
biodegradable substitute for synthetic polyacrylate in
various technical processes. In addition, cyanophycin might
also be of interest for other applications if the unknown
physical and material properties of this polymer are
revealed. Because of the low polymer content and the slow
growth of cyanobacteria resulting in only low cell densities,
cyanobacteria are not suitable for large-scale production of
cyanophycin (Schwamborn 1998), and sufficient amounts
of cyanophycin were hitherto not available.
The polymerization reaction is catalyzed by only one
enzyme, which is referred to as CphA (Ziegler et al. 1998).
The cphA genes from Anabaena variabilis ATCC 29413,
Anabaena sp. strain PCC7120, Synechocystis sp. strain
PCC6803, Synechocystis sp. strain PCC6308, Synechococcus
elongatus, Synechococcus sp. strain MA19 and others were
cloned and expressed in Escherichia coli (Aboulmagd et al.
2000;B e r ge ta l .2000; Hai et al. 1999;O p p e r m a n n - S a n i oe t
al. 1999; Ziegler et al. 1998). More recently, heterologous
expression of cphAwas also demonstrated at a small scale in
recombinant strains of Ralstonia eutropha, Corynebacterium
glutamicum,a n dPseudomonas putida (Aboulmagd et al.
2001). Whereas in cyanobacteria the molecular mass of the
polymer strands ranged from 25 to 100 kDa (Simon 1976),
the polymer from recombinant strains harboring cphA as
well as in vitro-synthesized polymer exhibited a much lower
range (25 to 30 kDa) and polydispersity. Furthermore, it was
found that the polymer isolated from recombinant strains
contained lysine as an additional amino acid constituent
(Aboulmagd et al. 2001; Ziegler et al. 1998). Recently, the
results of a detailed in silico analysis of the occurrence of
enzymes involved in cyanophycin metabolism was published
(Füser and Steinbüchel 2007).
Recently, the earlier postulated instability of recombinant
E. coli strains employed for cyanophycin production was
also confirmed in both DH1 and DH5α. This instability
may be caused by loss of the plasmid during fermentation.
However, as cyanophycin production continues in cultures
that rapidly appear to loose the ampicillin resistance
employed for selection and plasmid maintenance, other
explanations are also under consideration such as compe-
tition for Arg and Asp by both cyanophycin and the
ampicillin resistance protein and the theoretical possibility
that the ampicillin resistance protein could be trapped into
the cyanophycin granule or at least be made inaccessible to
the ampicillin.
Due to the wide knowledge of its metabolism and
available genetic tools, E. coli is one of the most commonly
used bacterial hosts for the production of recombinant
proteins (Lee 1996). Several expression systems have been
developed for technical-scale production of recombinant
proteins in E. coli based on the regulated trp, lac, or lambda
PL promoter (Hannig and Makrides 1998). The cultivation
of recombinant E. coli strains harboring cphA from
Synechocystis sp. strain PCC6803 at the 500-l scale for the
production of cyanophycin has been described (Frey et al.
2002). As the previously described method for the purifica-
tion of cyanophycin (Simon and Weathers 1976) is not
applicable to a large scale, a simplified method for isolation
of the polymer at the technical scale was elaborated.
Biosynthesis of cyanophycin was extensively studied in
the 1970s by Simon and coworkers (Simon 1971, 1976;
Simon and Weathers 1976). Later, this led to the identifi-
cation of cyanophycin synthetase enzymes and the encod-
ing genes (cphA) in various organisms (Ziegler et al. 1998;
Aboulmagd et al. 2000; Berg et al. 2000; Hai et al. 2002).
Subsequently, the enzymes involved in the degradation of
cyanophycin by intracellular cyanophcyinases of cyanobac-
teria (cphB) and extracellular depolymerases, like hydrolase
(cphE) and cyanophycinase (cphI) genes, were identified
(Obst et al. 2002, 2004; Obst and Steinbüchel 2004).
Elbahloul et al. (2005a,b) have found that inactivation of
the cyanophycinase gene in Acinetobacter resulted in
significantly less cyanophycin accumulation than the wild
type presumably due to a shortage of cyanophycin primer
molecules. On the contrary, cyanophycin is highly resistant
against hydrolytic cleavage by proteases such as trypsin,
pronase, pepsin, carboxypeptidases B, carboxypeptidase C,
and leucin-aminopeptidase, and cyanophycin is also resistant
against arginases (Simon and Weathers 1976).
Because the cyanophycin synthetase genes (cphA)o f
many cyanobacteria, and recently, also of other micro-
organisms were identified, cloned, and heterologously
expressed in other bacteria (Aboulmagd et al. 2001)
conferring the ability to produce comparably large amounts
of cyanophycin (up to 50% of CDW) in a much shorter
period of time (1–2 days) as compared to cyanobacteria
(about 4 weeks) and cyanophycin production was demon-
strated at the 30- to 500-l scale (Aboulmagd et al. 2001;
Frey et al. 2002; Voß and Steinbüchel 2006), the interest in
cyanophycin as a potential raw material has constantly
increased over the last few years. Improvement of fermen-
tation conditions, feeding regimes, and the possibility to
produce cyanophycin now by the employment of many
genetically engineered bacteria with industrial relevance
like R. eutropha, C. glutamicum,o rP. putida (Aboulmagd
et al. 2001) in complex but also in defined media make it
appear likely that further improvement of cyanophycin
production in bacteria will be achieved during future
studies. These studies may include elementary mode
analyses (Diniz et al. 2006) or more conventional
260 Appl Microbiol Biotechnol (2007) 77:257–267approaches involving experimental design using fermenter
arrays and principal component analyses.
In conclusion, large-scale fermentation processes for
cyanophycin production and downstream processing are
available for a number of different microorganisms able to
grow in different substrates, including the potato waste
stream Protamylasse™, and also, low cyanophycin yields
were reported in plants.
Production and economic aspects of fermentative
cyanophycin production
An important contribution to sustainability can be made by
the use of a considerable plant waste stream for the
production of renewable, biodegradable, and biocompatible
polymers and/or valuable chemicals that are now produced
on large scale from petroleum. Some of the polymer
classes to be developed may be expected to replace some
existing mineral petroleum-based polymers as soon as
competitive production prices can be obtained and/or
supporting measures will be taken to promote the use of
renewable resources. On the other hand, completely novel
types of biopolymers may be developed for completely
novel applications.
AVEBE, located in the northern part of The Netherlands,
is the largest potato-starch-producing company in the
w o r l di n v o l v e di ne x t r a c t i o n ,p r o c e s s i n g ,a n ds a l e so f
starch and starch-derived products. During processing of
potatoes for starch extraction, the main waste stream is
Protamylasse™.Annually,AVEBEproducesabout120,000m
3
of Protamylasse™ containing about 70,000 tons of dry
matter, mainly consisting of sugars (14,000 tons), organic
acids (13,300 tons), proteins and free amino acids
(18,000 tons). The amino acids arginine and aspartic acid
amounttoabout1,000tonseachandlysinetoabout700tons.
Currently, there is no proper outlet for this Protamylasse™
other than low value epandage (e.g., by Bos Agra-Service,
NL in which the salts present, such as potassium, are used as
fertilizer), whereas rough calculation shows that the total
intrinsic gross value of the valuable components in the
Protamylasse™ is about 45 million euros. A number of
researchobjectivesisnowinprogresstoaddsubstantialvalue
to the entire potato starch production chain (and thus its
economical feasibility). Protamylasse™ may be considered a
modelforotheragriculturalwaste streams,suchasgrassjuice
andbeetresidue.Itisnotcertainwhetherconcentrationsofall
mediumcomponentsintheProtamylasse™willbeoptimalto
sustain microbial growth and cyanophycin production, and it
is anticipated that additional medium components need to be
identified and/or tailor-made production strains constructed.
This will require a detailed analysis of Protamylasse™
components before and after the cyanophycin production
phase.
To calculate the economic feasibility of cyanophycin
production using Protamylasse™, several aspects need to
be included as follows:
– Necessary steps from potato starch and protein extrac-
tion, yielding Protamylasse™, to the final purified
product cyanophycin (which is considered an interme-
diate product for derived polymer types and N-
containing bulk chemicals) include: shipment to a
fermentation plant, dilution to 5–6% (v/v) using tap
water, removal of potato particles by filtration, disposal
(or alternative use) of particle fraction (60% DM),
loading of step up fermenters [to allow an microbial
inoculum concentration of 10% (v/v) per step; e.g.,
10→100→1,000→10,000→100,000 l], sterilization,
cooling, addition of ampicillin, inoculation, (batch)
fermentation, addition of acid and/or base for pH
control, cell harvesting and concentration, disposal or
recycling of spent Protamylasse™, cell disruption (not
for E. coli), cyanophycin extraction using pH 2,
neutralization, cyanophycin crystallization, precipita-
tion, purification, and storage.
– Yearly Protamylasse™ supply, 120,000 m
3; 70,000 tons
(60% DM)
– Protamylasse™ dry matter composition: amino acids
(18,000 tons), sugars (14,000 tons), organic acids
(13,300 tons), ash (22,200 tons). For further details
on the composition, see Elbahloul et al. (2005a, b).
– Small-scale fermentation process data: Protamylasse™
concentration, 5–6% (v/v); fermenter volume, 25 l;
strain E. coli DH1 (pMa/c5-914::cphA); temperature
37°C; maximal OD and cyanophycin yield reached
after 15 h; optimal pH 7.5–8.0; biomass yield 5–10 g/
l (CDW); cyanophycin content, 25% (w/w); cyanophy-
cin composition, Asp, 50%; Arg, 45%; Lys, 5%; E. coli
occasionally (5–10%) incorporates lysine in stead of
arginine; poly(Asp–Arg) is non-soluble in water at
neutral pH; poly (Asp–Arg–Lys) is soluble in water.
Assuming that most of the solid particles will be
removed from the Protamylasse™ by filtration, a yearly
amount of 48,000 m
3 of Protamylasse™ liquid juice will
become available, which is used at a 5% dilution during
fermentation, thus, providing a yearly amount of
960,000 m
3 of diluted fermentation broth. This volume
would be enough to run 9,600×100 m
3 fermenter volumes.
Further assuming a 1 week’s run time (including cleaning,
sterilization, fermentation, and harvest) a park of, e.g.,
185×100 m
3 or preferably 20×1,000 m
3 fermenter units
(step up units included) could be operated continuously.
With the current E. coli biomass yield of 5 g/l (CDM) with
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a yearly amount of 1,200 tons of purified cyanophycin. At
an estimated market price of € 1,000 per ton cyanophycin,
the Protamylasse™ juice fraction (40% v/v) would yield a
yearly income of only 1.2 million euros. However, by only
increasing the amount of microbial biomass from the actual
5 g/l (CDM, E. coli) to a realistic value of 100 g/l (CDM,
S. cerevisiae) with the same cyanophycin content of 25%
(w/w DM), this yearly income could be raised to 24 million
euros. If within the same fermentation run via so-called
process integration, in addition to cyanophycin, ethanol
also [yielding from 960,000 m
3 at 5% (v/v) about
48,000 m
3 ethanol and an additional yearly income of
27.4 million euros at $2.8 per US gallon, € 0.57 per liter)
could be produced using semi-aerobic fermentation with S.
cerevisiae, this yearly income could be further raised to
about 50 million euros. The Protamylasse™ particle
fraction can, in principle, also be used for cyanophycin
and ethanol production. Preliminary calculations using the
model of Golden Grain Energy, LLC (http://sec.edgar-
online.com/ 2004/06/14/0001104659-04-016859/Section7.
asp) suggest that the break-even point could roughly be
reached within about 3–5 years.
Further process improvements may be obtainable and are
necessary to make this process economically feasible.
These obtainable figures provide estimates as to the
investments and costs that will be necessary to start a
cyanophycin production fermentation facility. However,
before fermentative cyanophycin production on industrial
scale can be started, a number of bottlenecks should be
overcome. Table 2 lists current bottlenecks and proposed
measures for optimal and economically feasible cyanophy-
cin production.
Cyanophycin production in plants
Transgenic plants can be utilized to produce renewable
resources for industrial purposes in a CO2-neutral, environ-
mentally acceptable, and competitive way. Poly-3-hydroxy-
butyrate (PHB) was the first plastic-like compound
produced in plants (Poirier et al. 1992), followed by, e.g.,
poly-3-hydroxyalkanoate (PHA; Poirier 2002) and medium
chain-length PHA in potato (Romano et al. 2003, 2005) and
showed the feasibility to produce biopolymers in plants.
Recently, it has been shown that it is also possible to
produce cyanophycin in plants (Neumann et al. 2005). For
this, the Thermosynechococcus elongatus BP-1 cyanophycin
synthetase gene was expressed constitutively under a 35S
promoter in tobacco and potato plants. It was shown
that approximately 1.14 and 0.24% dry weight could be
accumulated in the cytosol of tobacco and potato leaves,
respectively. The size (35 kDa), amino acid composition
(Asp/Arg/Lys=1:1.05:0.1), and structure of the plant-
produced polymer was similar to that produced in transgenic
E. coli expressing the same gene; however, the amount and
molecular weight of the cyanophycin produced in plants was
much lower than that observed in bacteria (up to 50% dry
weight and 125 kDa in bacteria). The experiments have
provided proof of concept for the potential of producing
cyanophycin in plants.
Production of the cyanophycin biopolymer in potato is
of high interest to the potato starch industry. Production in
this plant does not require any additional infrastructure.
After processing of the potatoes, cyanophycin can be
isolated from the Protamylasse™. However, for commercial
application, the efficiency of cyanophycin accumulation in
potato has to be significantly improved.
Neumann et al. (2005) already indicated that directing
the cyanophycin synthetase into several other compart-
ments, such as the chloroplasts, could lead to increased
accumulation of cyanophycin. However, chloroplasts in the
cyanophycin-producing cells differ morphologically from
wild-type chloroplasts. There are fewer and smaller grana
stacks, and the growth rate is slower. One of the possible
explanations for these properties is depletion of amino acid
resources as a result of cyanophycin production (Neumann
et al. 2005). The pioneering experiments by Neumann et al.
(2005) have opened up a new field for the production of
cyanopycin in agricultural crops and show that more
research is needed before being introduced into agricultural
production (Conrad 2005).
Additional strategies
Priming cyanophycin elongation
In in vitro studies, it has been shown that cyanophycin
synthetase works more efficiently with a (β-Asp/Arg)3/Arg
primer. In planta production of such a primer may enhance
cyanophycin biosynthesis. Cyanophycinases encoded by
the chpB and chpE genes can degrade cyanophycin into
arginine–aspartic acid dipeptides (Asp–Arg) which cannot
be used as primer for cyanophycin biosynthesis.
The cphI gene encodes a plant-type asparaginase able to
hydrolyze β-Asp/Arg bonds and that, thus, may be
responsible for the last step in cyanophycin degradation.
Bacterial studies have indicated that cphI expression
contributes to a higher cyanophycin level.
It might be possible to use a poly-Asp backbone as
primer for cyanophycin biosynthesis. This peptide can be
produced by ribosomal protein biosynthesis. The gene
should be under the control of a low-level promoter to
prevent the production of many peptides, and thus, the
production of many low molecular weight polymers.
262 Appl Microbiol Biotechnol (2007) 77:257–267Optimization of amino acid biosynthesis
It has been shown that cyanophycin synthetase uses arginine
andasparticacidasits major aminoacidsource but thatitalso
canincorporatelysineinthecyanophycinpolymer(Bergetal.
2000). It is unclear how this affects the properties of the
polymer. Based on the chemical composition of Protamy-
lasse™ and the affinity of the enzyme for arginine and
lysine, it can be proposed that lysine accounts for 1.5% of
the total cyanophycin. To reduce this amount, three strategies
are possible, i.e., improve biosynthesis of arginine, reduce
the level of lysine, and/or transform lysine into arginine.
It is possible that the availability of substrates (Asp and
Arg) in plants is limiting or off-balance. Therefore, it is
important to identify the organs that have the highest
concentrations of available substrates and to investigate
whether the substrate supply can be enhanced by introduc-
tion of genes involved in substrate production.
Table 2 Economical and technological bottlenecks and proposed measures
Bottleneck Proposed measure(s)
Investments, including costs for fermentation
and downstream processing equipment
The calculation provided here suggests that these may be acceptable
Costs for the production of cyanophycin,
cyanophycin-derived products and for
downstream processing of biomass
Construction of a sufficiently productive microbial strain to convert or simply
utilize constituents of plant waste streams like Protamylasse™ and to
incorporate these compounds, presumably amino acids, into the cyanophycin
polymer chain during cyanophycin biosynthesis
Phenotypic instability of E. coli production
strains used until now, DH1 and DH5α,
containing plasmid pMa/c5-914::cphA6803
Construction of stable strains with integrated copies of the cyanophycinsynthesis genes
Low biomass yields of the E. coli strains used Since not all components present in the current source of Protamylasse™ may
have the proper concentration for current laboratory strain(s), an optimization may
require the addition of substrates other than Protamylasse™, for example other plant
waste streams. Sufficient provision of amino acids like arginine should be ensured
during the production phase
Optimization of microbial biomass formation By using yeasts as alternative production organisms biomass yields could be increased to
100 g/l CDM for S. cerevisiae [factor 20×] or 150 g/l CDM for Pichia pastoris [factor 30×]
if in Protamylasse™ the same yields can be obtained as in dedicated growth media
Sub-optimal fermentation processes Fermentation technology and feeding regimes have to be developed for optimum amino
acid utilization or biosynthesis from Protamylasse™ or other plant waste streams
Generation of valuable side stream particle
fraction of Protamylasse™
Alternative use of the side stream particle fraction of Protamylasse™, e.g. by using
cyanophycin producing filamentous fungi
Co-production with, e.g., ethanol When using S. cerevisiae as the production organisms and (semi-) anaerobic fermentation
both cyanophycin and ethanol could possibly be produced during the same run
Costs for cyanophycin extraction Development of alternative cheap cyanophycin extraction methods using, e.g.,
hydro-cyclone equipment for the non-soluble fraction
Cost-efficient production of cyanophycin in plants The transfer of the bacterial cyanophycin synthetase gene (cphA) into eukaryotic hosts,
mostly plants and its effective expression in suitable organs or cell compartments is
a major step (see below)
Efficacy of downstream processing Downstream processing has to be adapted and optimized for cyanophycin or cyanophycin
derivatives containing biomass, which will be either bacterial cells or eukaryotic (mostly
plant) cells or tissues
Lack of insight in possible modifications of
cyanophycin, their impact on cyanophycin
properties and market potential
The diverse possibilities to modify the cyanophycin molecule chemically or enzymatically
has to be exhaustingly explored to identify all potential key applications for cyanophycin-
derived products and to find the most suitable products with regard to market potential
and the possibility of their commercialization
Lack of knowledge concerning properties
of known cyanophycin synthetases and their
genetic engineering
The possibility to modify the active sites of the cyanophycin synthetases in order to
change its substrate specificity and to allow the production of cyanophycin derivatives
has to be determined
Insufficient insight in all possible applications
for cyanophycin as a polymer or as a starting
material for chemical syntheses
The exploitation of cyanophycins and cyanophycin-derived molecules as substitutes
for well established industrial products or as renewable raw materials has to be
determined precisely
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by fermentation or in plants
As for some other commodities, depending on production
price, market volume and final product price (Fig. 2) for
cyanophycin specialty product applications, fermentation is
the preferred production method (roughly below 20.000 tons
annually), whereas for bulk quantities of cyanophycin, the
production directly in plants is preferred (above
20,000 tons). Therefore, for the production of cyanophy-
cin-derived bulk quantities of nitrogen-containing chem-
icals, plants are considered the best production organisms,
whereas for specialty polymers, fermentation may be the
preferred production technology.
Assuming that a typical fermentative production of a
bulk product, such as lysine, citric acid or glutamic acid
costs about € 1,500 per ton and that these costs consist of:
€ 500 for the raw materials, € 500 for the fermentation
process, and € 500 for recovery and purification. The
advantage of producing in plants is that both the raw
material costs and the fermentation costs can almost be
neglected. On the other hand, recovery costs could be much
higher. For the sake of the reasoning, it is assumed that
recovery costs for cyanophycin production in plants will be
the same as in the case of fermented production, i.e., € 500
per ton. In case of a fermentation process, a typi<
cal production volume for a company would be in the
order of magnitude of 100,000 tons/year. The turnover
would then be 150 million euros per year (i.e., € 1,500 per
ton  100,000 tons/year). In the case of production in plants,
as raw material and fermentation costs are negligible, cost
savings would be 100 million euros per year. This would be
the maximum advantage, as this calculation does not include
any costs for the production of the crop nor any additional
costs for biorefining of the crop and treatment of side
products. A similar reasoning would bring a maximum
advantage for a product with a typical company production
volume of 20,000 tons per year, such as the case with a
medium-sized monomer. In this case, cost savings per ton
would be higher, but as the volume is much smaller, the
maximum advantage could be around 70 million euros. For
specialty products with a volume of 300 tons per year
(enzymes), a maximum advantage is estimated to be in the
order of 5–10 million euros. For pharmaceutical production
with a volume of 10 tons per year, the advantage would be
around 0.5–1.5 million euros, as the volume would be small
and production costs would mainly be ascribed to recovery.
Other plant side streams
In addition to the possible exploitation of Protamylasse™,a
large number of other plant side streams may be used for
cyanophycin production, including grass juice, which
remains after protein extraction or beet or cane molasses
remaining after sugar extraction. It is foreseen that with the
production of biodiesel and bioethanol, large volumes of
side streams will become available, all containing major
protein quantities. Such streams will include dried distillers
grain and solubles (DDGS) from corn and wheat, press
cake from palm oil and rape seed oil. These streams all
have in common a very low cost price, which implies that
when used as a microbial growth medium, a major
contribution to fermentation process costs (about 30%)
can be eliminated. However, it is important to note that
none of any waste stream (to be) considered has exactly the
same chemical or element composition as the production
organism and its product(s), including, e.g., CO2. This
implies that in each fermentation process to be developed
using plant waste streams as substrates, limiting compo-
nents should be supplemented. For the identification of
such limiting components, fermentation test runs should be
performed, preferably supported by statistic analyses such
as elementary mode analysis (Diniz et al. 2006). Only after
performing such exercises can reliable estimates of integral
project costs be obtained.
Cyanophycin-derived bulk chemicals
Cyanophycin can be hydrolyzed to its constituent amino
acids, aspartic acid, and arginine. These amino acids may be
utilized directly in food and pharmaceutical applications.
However, based on the chemical structure of these amino
acids and the presence of functionalized nitrogen-containing
groups,itispossibletoanticipatetheirconversiontoanumber
of industrial chemicals, including:
a) Arginine may be converted to 1,4-butanediamine. 1,4-
diaminobutane, derived from petrochemistry, is cur-
rently used as a co-monomer in the production of
Fig. 2 Cyanophycin production in planta or by fermentation. Gray
square: raw material costs, filled square: fermentation costs, open
square: recovery and purification costs
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is estimated to be in the range of 10,000s tons per year
with a value of > € 1,600 per ton.
b) Conversion of aspartic acid to acrylonitrile is also
envisaged. Using current petrochemical technology, the
current worldwide market volume of acrylonitrile is
2.7–5×10
6 tons per year and a price of about € 800–
1,000 per ton.
Other chemicals which could be obtained from cyano-
phycin but are currently prepared from fossil resources
include, e.g., 1,4-butanediol and urea.
The production of cyanophycin by plants will drastically
reduce the cost price, potentially below € 1,000 per ton.
This will enable the production of functionalized bulk
chemicals such as 1,4-diaminobutane, and possibly, also
acrylonitrile. The transition from mineral oil to plant-based
precursor production has a considerable impact. The use of
ammonia for the incorporation of nitrogen into chemicals is
very important, but also very energy-intensive. Therefore, if
the incorporation of nitrogen can be realized in systems
based on plant (rest) streams in the form of protein or
amino acid precursors, then this will yield considerable
energy savings.
Cyanophycin-based biopolymers
Poly-aspartic acid is derived from cyanophycin after the
hydrolytic removal of arginine. This polymer has properties
that are very similar to poly-acrylic acid. The cost price of
this polymer can be set on 1,000€/ton in the cost
calculations for arginine here above. As the volumes of
these products will be similar, only 1,000 tons/year will be
manufactured. Higher market prices might be obtained for
special applications in food and/or pharmaceutical applica-
tions. This might change the cost structure of arginine in a
way that market volumes might double or triple.
Cyanophycin as such might have applications as a
polymer. Furthermore, derivatives obtained by enzymatic/
genetic and/or chemical modifications might give valuable
properties. Without thorough investigations, we cannot
anticipate on the value of these polymers. Utilization in
this area can be expected after 10 to 12 years after the
beginning of the proposed research approaches for research
and development.
Possible cyanophycin modifications, applications
for bulk chemicals and for polymers
By incorporating other amino acids, different types of
polymers can be made. So far, several cyanophycins have
been produced in recombinant strains of E. coli up to 50%
dry weight. However, especially for health care medical and
food packaging applications, E. coli may not be the best
commercial production organism. Therefore, the develop-
ment of alternative food-grade production organisms is also
one of the objectives of the current activities. One suitable
candidate may be the bakers yeast Saccharomyces cerevisiae
(and others: see above). In addition, being stable at a pH
between 3 and 9, cyanophycin can also be hydrolyzed in
concentrated volumes into its pure components, arginine and
aspartic acid. This would make the whole process a novel
biological extraction procedure for the selected amino acids.
Outlook
Given the anticipated cost development for fossil energy
carriers and environmental regulations, the chemical indus-
try is facing increasing financial pressure and is thus
looking for possibilities to broach new resources as a basis
for polymer production. Important considerations in this
search are to lower energy costs and prices of raw material
and to develop cheaper and more sustainable production
processes.
Unlike poly-γ-glutamic acid and poly-ɛ-lysine, cyano-
phycin has not been commercialized yet. Cyanophycin can
be broken down into the individual amino acids that can be
used as building blocks in various industrial processes.
Because of its homogeneous structure and composition, the
cyanophycin polymer and its derivatives also appear to be
good candidates as starting materials for the production of
nitrogen-rich commodity products, which are based on
nitrogen-rich chemicals, like, for example, nylons. For
example, for poly(aspartic acid) which is the polymer
backbone of cyanophycin, various applications have been
developed ranging from water-softening or detergent
applications to applications in the paper, building material,
petroleum or leather industry, in cosmetics, as well as many
dispersant applications.
Cyanophycin can be chemically converted into a
polymer with a reduced arginine content, which might be
used like poly-aspartic acid as a biodegradable substitute
for synthetic polyacrylate in various technical processes
(Schwamborn 1998). Thus, cyanophycin may find applica-
tions in cyanophycin-derived bulk chemicals and in
cyanophycin-based biopolymers.
It can be expected that economical activities can be
developed within the following areas, such as: fermentation
industry, biopolymer production, processing, modification
and product development (also for medical technology),
packaging industry, food and feed supplementation indus-
tries and, last but not least, state-of-the-art technology
(which, in turn, will attract additional financial sources and
economical activities). It should be emphasized, however,
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these are so far only potential applications.
On the one hand, this development will lead to the
substitution of chemicals that are now produced at the cost
of fossil raw materials, such as oil. As oil may be depleted in
about 50 years, and as there seems to be a correlation of the
use of fossil raw materials with climate changes, it is essential
to develop alternatives. The anticipated alternatives can be
produced by fermentation and, in principle, by plant produc-
tion systems, and so, giving a new economic and knowledge
intensive value to the fermentation industry and/or to
agriculture. On the other hand, novel types of polymers will
be developed that do not simply replace existing applications
but that will enter novel product markets.
Elements of the contents of this paper are included in a
dedicated patent application (Elbahloul et al. 2006).
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